首页> 美国卫生研究院文献>World Journal of Gastrointestinal Pathophysiology >Mesenteric ischemia: Pathogenesis and challenging diagnostic and therapeutic modalities
【2h】

Mesenteric ischemia: Pathogenesis and challenging diagnostic and therapeutic modalities

机译:肠系膜缺血:发病机理及具有挑战性的诊断和治疗方式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenteric ischemia (MI) is an uncommon medical condition with high mortality rates. ΜΙ includes inadequate blood supply, inflammatory injury and eventually necrosis of the bowel wall. The disease can be divided into acute and chronic MI (CMI), with the first being subdivided into four categories. Therefore, acute MI (AMI) can occur as a result of arterial embolism, arterial thrombosis, mesenteric venous thrombosis and non-occlusive causes. Bowel damage is in proportion to the mesenteric blood flow decrease and may vary from minimum lesions, due to reversible ischemia, to transmural injury, with subsequent necrosis and perforation. CMI is associated to diffuse atherosclerotic disease in more than 95% of cases, with all major mesenteric arteries presenting stenosis or occlusion. Because of a lack of specific signs or due to its sometime quiet presentation, this condition is frequently diagnosed only at an advanced stage. Computed tomography (CT) imaging and CT angiography contribute to differential diagnosis and management of AMI. Angiography is also the criterion standard for CMI, with mesenteric duplex ultrasonography and magnetic resonance angiography also being of great importance. Therapeutic approach of MI includes both medical and surgical treatment. Surgical procedures include restoration of the blood flow with arteriotomy, endarterectomy or anterograde bypass, while resection of necrotic bowel is always implemented. The aim of this review was to evaluate the results of surgical treatment for MI and to present the recent literature in order to provide an update on the current concepts of surgical management of the disease. Mesh words selected include MI, diagnostic approach and therapeutic management.
机译:肠系膜缺血(MI)是一种不常见的医学疾病,死亡率高。 M1包括血液供应不足,炎性损伤以及肠壁最终坏死。该疾病可分为急性和慢性MI(CMI),第一类可分为四类。因此,急性MI(AMI)可能是由于动脉栓塞,动脉血栓形成,肠系膜静脉血栓形成和非阻塞性原因引起的。肠损伤与肠系膜血流量减少成正比,可能因可逆性局部缺血而导致的最小病变,经壁损伤以及随后的坏死和穿孔。在超过95%的病例中,CMI与弥漫性动脉粥样硬化疾病有关,所有主要的肠系膜动脉均表现为狭窄或闭塞。由于缺乏具体体征或由于有时安静的表现,这种病常常仅在晚期才被诊断出来。计算机断层扫描(CT)成像和CT血管造影有助于AMI的鉴别诊断和管理。血管造影术也是CMI的标准标准,肠系膜双工超声检查和磁共振血管造影也很重要。 MI的治疗方法包括医学和外科治疗。外科手术包括通过动脉切开术,动脉内膜切除术或顺行旁路术恢复血流,同时总是切除坏死肠。这篇综述的目的是评估MI的外科治疗结果并提供最新文献,以提供有关该疾病外科治疗当前概念的最新信息。选择的网格词包括心梗,诊断方法和治疗管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号